Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cardiff Oncology, Inc. (DE:XE7C)
FRANKFURT:XE7C
Cardiff Oncology (XE7C) Ownership Overview
3.57% Insiders
4.82% Mutual Funds
1.14% Other Institutional Investors
5.89% ETFs
84.58% Public Companies and Individual Investors
The ownership structure of Cardiff Oncology (DE:XE7C) stock is a mix of institutional, retail, and individual investors. Approximately 11.85% of the company’s stock is owned by Institutional Investors, 3.57% is owned by Insiders, and 84.58% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 18, 2024 | xxxxxxxxxxxxx | $36708 | |
| Dec 16, 2024 | Renee Tannenbaum Director | xxxxxxxxxxxxx | $34200 |
| Dec 12, 2024 | Gary Pace Director | xxxxxxxxxxxxx | $940199 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $60075 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $120150 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,107,252 | Insider | 3.17% | 7,196,266 | |
| 2,073,292 | Institution | 3.12% | 7,080,292 | |
| 1,854,892 | Institution | 2.79% | 6,334,456 | |
| 1,539,047 | Institution | 2.31% | 5,255,846 | |
| 438,247 | Institution | 0.66% | 1,496,614 | |
| 402,440 | Institution | 0.61% | 1,374,333 | |
| 192,727 | Institution | 0.29% | 658,163 | |
| 139,603 | Institution | 0.21% | 476,744 | |
| 121,293 | Institution | 0.18% | 414,216 | |
| 113,788 | Insider | 0.17% | 388,586 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,854,892 | Institution | 2.79% | 6,334,456 | |
| 438,247 | Institution | 0.66% | 1,496,614 | |
| 402,440 | Institution | 0.61% | 1,374,333 | |
| 192,727 | Institution | 0.29% | 658,163 | |
| 121,293 | Institution | 0.18% | 414,216 | |
| 53,116 | Institution | 0.08% | 181,391 | |
| 27,727 | Institution | 0.04% | 94,688 | |
| 24,797 | Institution | 0.04% | 84,682 | |
| 18,700 | Institution | 0.03% | 63,861 | |
| 18,290 | Institution | 0.03% | 62,460 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Cardiff Oncology, Inc. (DE:XE7C)?
According to the latest TipRanks data, approximately 1.14% of the company's stock is held by institutional investors, 3.57% is held by insiders, and 84.58% is held by retail investors.
What percentage of Cardiff Oncology, Inc. (DE:XE7C) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.14% of Cardiff Oncology, Inc. (DE:XE7C) stock is held by institutional investors.
What percentage of Cardiff Oncology, Inc. (DE:XE7C) stock is held by retail investors?
According to the latest TipRanks data, approximately 84.58% of Cardiff Oncology, Inc. (DE:XE7C) stock is held by retail investors.
Who owns the most shares of Cardiff Oncology, Inc. (DE:XE7C)?
Gary Pace owns the most shares of Cardiff Oncology, Inc. (DE:XE7C).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.